Troy A. Ignelzi - Sep 30, 2022 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Chief Financial Officer
Signature
/s/ Troy Ignelzi
Stock symbol
KRTX
Transactions as of
Sep 30, 2022
Transactions value $
-$3,444,117
Form type
4
Date filed
10/4/2022, 07:25 PM
Previous filing
Aug 11, 2022
Next filing
Nov 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Sale -$558K -2.46K -9.85% $227.05 22.5K Sep 30, 2022 Direct F1
transaction KRTX Common Stock Sale -$645K -2.82K -12.52% $228.74 19.7K Sep 30, 2022 Direct F2
transaction KRTX Common Stock Sale -$1.19M -5.19K -26.35% $229.77 14.5K Sep 30, 2022 Direct F3
transaction KRTX Common Stock Sale -$7.61K -33 -0.23% $230.49 14.5K Sep 30, 2022 Direct
transaction KRTX Common Stock Sale -$230K -1K -6.91% $230.02 13.5K Oct 3, 2022 Direct F4
transaction KRTX Common Stock Sale -$463K -2K -14.85% $231.30 11.5K Oct 3, 2022 Direct F5
transaction KRTX Common Stock Sale -$255K -1.1K -9.59% $232.00 10.4K Oct 3, 2022 Direct F6
transaction KRTX Common Stock Sale -$93.3K -400 -3.86% $233.20 9.97K Oct 4, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.00 to $227.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (6) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.31 to $229.27, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.45 to $230.42, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.11, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.00 to $231.55, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.00 to $232.01, inclusive.